About 5 to 7 percent of all diagnosed diabetes cases in the United States are type 1. According to the CDC’s National Diabetes Statistics Report, roughly 2.1 million Americans have been diagnosed with type 1 diabetes out of 29.1 million total diagnosed diabetes cases. That puts type 1 at approximately 7% of the total, though some estimates run slightly lower depending on how undiagnosed cases are counted.
Where These Numbers Come From
The CDC estimates 29.1 million Americans have been diagnosed with diabetes overall. Of those, 2.1 million have type 1, including 1.8 million adults aged 20 and older and 314,000 children and adolescents. The remaining cases are overwhelmingly type 2, with a small fraction made up of gestational diabetes and rarer forms.
These figures likely undercount type 1 in adults. Between 4% and 14% of people diagnosed with type 2 diabetes may actually have a slow-developing autoimmune form called latent autoimmune diabetes in adults (LADA). LADA shares features of both types: it involves the same immune attack on insulin-producing cells as type 1, but it progresses more gradually, sometimes taking years before insulin is needed. Because these patients are often middle-aged and may initially respond to standard type 2 treatments, they’re frequently misclassified.
Why Type 1 and Type 2 Are Fundamentally Different
Type 1 diabetes is an autoimmune disease. The immune system attacks and destroys the cells in the pancreas that produce insulin. Blood sugar levels begin to rise once roughly 50% or more of those cells are destroyed, based on data from pancreatic surgery studies. The earliest sign is usually a spike in blood sugar after meals, when more insulin is needed. As destruction continues, fasting blood sugar climbs too, and the body loses the ability to regulate glucose at all. People with type 1 produce little to no insulin and need it from an external source to survive.
Type 2 diabetes, which accounts for roughly 90 to 95% of cases, works differently. The pancreas still makes insulin, but the body’s cells become resistant to it. Over time, the pancreas may struggle to keep up with demand, but the underlying problem is insulin resistance rather than immune destruction. Risk factors like weight, physical activity level, and age play a much larger role in type 2 than in type 1.
It’s Not Just a Childhood Disease
Type 1 diabetes was long called “juvenile diabetes,” and many people still assume it only appears in children. The data tell a very different story. In a study of more than 1.3 million U.S. adults with type 1, 37% reported being diagnosed after age 30. Broader estimates suggest that up to 62% of all type 1 cases develop in people older than 20.
This matters because adult-onset type 1 is easy to mistake for type 2. An adult who develops type 1 doesn’t fit the stereotype of a child in a hospital, and their doctor may default to a type 2 diagnosis. The key difference is whether the body is still producing insulin. A blood test measuring a molecule called C-peptide can help sort this out: very low levels point toward type 1, while higher levels suggest the pancreas is still making insulin, consistent with type 2. Doctors can also test for specific autoantibodies that signal the immune system is targeting insulin-producing cells.
What Drives Type 1 Risk
Genetics play a significant but incomplete role. Specific gene variants in a region of the immune system account for about 40% of the inherited risk for type 1 diabetes. People who carry certain combinations of these genes face the highest risk. But genetics alone don’t explain the whole picture. Identical twins, who share 100% of their DNA, don’t always both develop type 1, which means environmental triggers are involved too.
Researchers suspect that infections, changes in gut bacteria, and other environmental factors may set off the autoimmune process in genetically susceptible people. The initial trigger appears to cause stress and damage to insulin-producing cells, which then alerts the immune system. Once the immune system identifies those cells as targets, it mounts a sustained attack that gradually destroys them.
Why the Percentage Matters
Being a small fraction of all diabetes cases creates real problems for people with type 1. Public conversations about diabetes overwhelmingly focus on type 2, including prevention messages centered on diet and exercise. Those messages don’t apply to type 1, which can’t be prevented through lifestyle changes. Funding, awareness campaigns, and even clinical training tend to skew heavily toward the far more common type 2.
Misdiagnosis is one tangible consequence. When adults develop type 1 and get labeled as type 2, they may spend months or years on the wrong treatment plan, with their blood sugar poorly controlled and their remaining insulin-producing cells continuing to deteriorate. Getting the correct diagnosis means getting the right treatment sooner, which makes a meaningful difference in long-term health outcomes.